WebNov 17, 2016 · information contained herein must not be altered or deleted. Additional information may be appended to the SDS, but it must be marked clearly to indicate that it is not part of the original. Page 1 of 8 1. Identification 1.1. Product identifier Product Identity Biostate® Alternate Names Biostate® (Human Coagulation Factor VIII, and human von WebVon Willebrand Factor/FVIII Plasma Concentrate (Biostate®) A human plasma-derived product, available from blood bank May be required in Type 1 vWD if severe bleeding or unresponsive to DDAVP Used to treat bleeding in patients with Type 2 and Type 3 vWD. Each reconstituted vial of Biostate® contains 50 IU/ml FVIII and 100 IU/ml von …
Bio-Statin Uses, Side Effects & Warnings - Drugs.com
WebApr 2, 2024 · nausea. puffiness or swelling of the eyelids or around the eyes. sensation of burning, warmth, heat, numbness, tightness, or tingling. skin rash, hives, or itching. … WebProphylaxis & treatment of non-surgical & surgical bleeding in patients w/ von Willebrand disease (VWD) when desmopressin treatment is ineffective or contraindicated; bleeding … durham bulls account manager
Comparison of the pharmacokinetics of two von Willebrand …
WebJan 24, 2024 · Stop using Bio-Statin if you have mouth irritation. Bio-Statin may cause serious side effects. Call your doctor at once if you have: fast heart rate; trouble … WebApr 9, 2009 · All subjects will receive Biostate® [SP] as required to manage their haemophilia condition for an estimated period of 6 months (or minimum of 50 exposure days) to assess efficacy and safety of the product. This part of the study is open-label. Part 3: Repeat pharmacokinetic assessment. http://www.nzblood.co.nz/assets/Transfusion-Medicine/PDFs/Biostate-Human-Coagulation-Factor-VIII-Patient-Information.pdf cryptococcus pdf